Klion (Metronidazole)

Metronidazole is reduced inside anaerobic microorganisms, producing reactive nitro radicals that damage DNA and other critical biomolecules. This disruption of nucleic acid synthesis leads to cell death, effectively clearing the infection caused by susceptible bacteria and protozoa.

The dosage of Klion is determined by the prescribing healthcare professional based on the specific infection, severity, and patient characteristics. Only a qualified prescriber should set the dose and duration of therapy.

Safety in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Klion.

To order Klion, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Klion (metronidazole) belongs to the nitroimidazole class, which is generally considered first‑line for bacterial vaginosis and trichomoniasis. Alternatives such as tinidazole have similar efficacy but may differ in dosing frequency or side‑effect profile. Choice of therapy depends on clinical judgment, patient tolerance and local resistance patterns.

Klion should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and effectiveness.

Klion is a vaginal formulation intended for local application. The prescribed dose is inserted into the vagina using the supplied applicator or as directed by the healthcare professional, typically once daily for the duration prescribed.

Serious adverse reactions can include severe allergic responses such as rash, hives, or swelling, as well as rare but critical conditions like Stevens‑Johnson syndrome, liver toxicity, seizures, and significant gastrointestinal upset. Patients should seek immediate medical attention if any of these symptoms occur.

Klion should not be used by individuals with a known hypersensitivity to metronidazole or other nitroimidazole compounds. Caution is also advised for patients with severe liver disease, those taking interacting medications such as warfarin or lithium, and anyone who is pregnant or breastfeeding without medical guidance.